Candidate Biomarkers Associated With Circulating Tumor Cell Status in Metastatic Colorectal Cancer
Journal of Clinical Laboratory Analysis · 2025
DOI: 10.1002/jcla.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Berkcan Doğan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Institute of Health Sciences, Bursa Uludag University, Bursa, Türkiye. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neoplastic Cells, Circulating, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bursa Uludag University Scientific Research Projects Unit, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) ranks as the third most prevalent cancer worldwide. Recent studies suggest the promising potential of microRNAs (miRNA) in predicting the status of circulating tumor cells (CTC), and their combined analyses could pave the way for significant advancements in assessing the risk of metastatic cancer. Here, we investigate the circulating miRNA signatures associated with CTC status in metastatic CRC (mCRC).
Methods
The CTC status of mCRC patients was assessed using AdnaTest ColonCancer technology, which detects tumor cells using an immunomagnetic approach and characterizes them based on colon‐specific surface markers. The miRNA profiles were analyzed using the Agilent miRNA microarray in 8 CTC‐positive, 8 CTC‐negative, and eight healthy individuals. The functional implications of dysregulated miRNAs and their interactions with target mRNAs, TFs, and lncRNAs were determined through a comprehensive in silico analysis. Candidate miRNAs that were differentially expressed in CTC‐positive and CTC‐negative groups, which have prior evidence for their role in CRC biology, were validated using qPCR.
Results
We identified two groups of dysregulated miRNAs associated with CTC status and multiple candidate biomarkers in suggested miRNA regulatory networks. Three miRNAs (hsa‐miR‐199a‐5p, hsa‐miR‐326, hsa‐miR‐500b‐5p), which were downregulated in the CTC‐positive group compared to the CTC‐negative group, were confirmed by qPCR and prioritized as candidate predictors of CTC status in mCRC.
Conclusion
Our findings suggest biomarker candidates that can be used to predict CTC status in individuals with mCRC. This might also provide new insights into new translational medicine applications in the management of mCRC through miRNA‐based CRC‐associated CTC detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, Institute of Health Sciences, Bursa Uludag University, Bursa, Türkiye.
- Faculty of Medicine, Department of Medical Genetics, Bursa Uludag University, Bursa, Türkiye.
- Faculty of Arts and Science, Department of Molecular Biology and Genetics, Bursa Uludag University, Bursa, Türkiye.
- Faculty of Medicine, Department of General Surgery, Bursa Uludag University, Bursa, Türkiye.
- Faculty of Medicine, Department of Medical Oncology, Bursa Uludag University, Bursa, Türkiye.
ORCID-Profile: Berkcan Doğan, Dilek Pirim, Özgen Işık, Türkkan Evrensel
Förderung
- Bursa Uludag University Scientific Research Projects Unit
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Doğan, B., Pirim, D., Işık, Ö., & Evrensel, T. (2025). Candidate Biomarkers Associated With Circulating Tumor Cell Status in Metastatic Colorectal Cancer. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70013
Vancouver
Doğan B, Pirim D, Işık Ö, Evrensel T. Candidate Biomarkers Associated With Circulating Tumor Cell Status in Metastatic Colorectal Cancer. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70013
BibTeX
@article{Doan2025,
author = {Doğan, Berkcan and Pirim, Dilek and Işık, Özgen and Evrensel, Türkkan},
title = {Candidate Biomarkers Associated With Circulating Tumor Cell Status in Metastatic Colorectal Cancer},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
doi = {10.1002/jcla.70013}
}
EUVIMED